3rd Annual Biosimilars India 2012

“Perfect blend of the topics based in biosimilars. All the speakers were well educated and experienced on the respective topics”

Anita Ghagare , Senior Manager, Unichem Laboratories

“The conference was useful in providing knowledge on regulatory guidelines and process development”

Mannan Khambati , Senior Manager, Bharat Serums and Vaccines

3RD ANNUAL BIOSIMILARS INDIA 2012

3^rd Annual Biosimilars India – Now in Hyderabad

India 's biotechnology sector is the third largest in the Asia Pacific region, after Australia and China . The industry is now worth more that US$4 billion, growing from around US$3 billion in 2009, and tripling in size in the last 5 years alone.

Following two successful Biosimilars events in 2010 and 2011– Biosimilars India is now coming to Hyderabad !

With a 2-day strategic conference and post-conference workshop on Clinical Trials, Biosimilars India 2012 will bring together key stakeholders in the biopharmaceutical industry to learn about the latest industry developments and innovative commercialisation strategies that will propel your biosimilar strategies to the next level!

Gain in-depth information on the most vital subjects including:

Regulatory landscape update on India , US, Europe and Japan
Commercialisation strategies discussed for regulated, semi-regulated and emerging markets
Patent issues tackled to capitalise on soon to be expired patents
Investments opportunities to drive development of India biosimilars

View the full agenda

New for 2012!

PRE-CLINICAL AND CLINICAL TESTING WORKSHOP

Join us for a hands-on workshop on pre-clinical and clinical trials for development of biosimilars. This interactive day will address your most critical challenges enabling you to perform successful and timely trials.

Who will you meet?

Domestic and international regulators
Leading biopharmaceutical and biotechnology companies
Top-level investors, technology and equipment suppliers
Other key stakeholders in the biopharmaceutical community

Companies which attended our previous Biosimilars events include:

Abbott Healthcare
Abexome Biosciences
ACG Value Links LLP
Apotex Research
Atharva Life Sciences Consulting
Aveta Lifesciences
Beximco Pharmaceuticals
Biopharmax India
Biotechnology Industry Research Assistance Program
(BIRAP)
BRG
CBC Corporation (India)
Celltrion Healthcare Co
CFR Pharmaceuticals
Chemet
Cipla
Citi Group Global Markets India
Clinton Health Access Initiative
Corporacion Farmaceutica Recalcine
D2L Pharma Research Solutions
DDN
Dr Reddy's Laboratories
Eisai Co
Fresenius Kabi Oncology
G C Chemie Pharmie
Glenmark Pharma
Gufic Biosciences
Hindustan Antibiotics
IPCA Laboratories
Jubilant Organosys
Kilitch Drugs (India)
Laboratorios Recalcine
LG Life Sciences India
Manipal Accunova
Merck India
Millipore India
MS University
MSD Technology Singapore Pte
Novartis Healthcare
Pfizer Pharmaceutical India
Pfizer Worldwide R&D
Piramal Healthcare
Proxy Laboratories
Quintiles Research India
Rakindo Developers P
Samsung
Shah Pharmachem Co
Sharda Chem
Sigma Aldrich India
Summit Pharmaceuticals International Corporation
Systematix Shares & Stocks (I)
The Boston Consulting Group India
Themis Medicare
Torrent Pharmaceuticals
Troikaa Pharma
Universal Consulting India
USV
Vivo Bio Tech
Wipro GE Healthcare